Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for ... Cassava Sciences, Inc.February 8, 2021 GMT AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer’s disease, today announced significant program progress and expected milestones for 2021. “We started 2021 with tremendous momentum, led by results of a 6-month interim analysis from an...
Source: apnews.com